Article Type
Article
Changed
Thu, 12/15/2022 - 15:11
Display Headline
New Treatment Option for Renal Cell Carcinoma

Article PDF
027010031.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 27(1)
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Page Number
31
Legacy Keywords
renal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitorrenal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitor
Sections
Pharmacology
Clinical Topics & News
Author and Disclosure Information

Author and Disclosure Information

Article PDF
027010031.pdf
Article PDF
027010031.pdf

Issue
Federal Practitioner - 27(1)
Issue
Federal Practitioner - 27(1)
Page Number
31
Page Number
31
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Article Type
Article
Display Headline
New Treatment Option for Renal Cell Carcinoma
Display Headline
New Treatment Option for Renal Cell Carcinoma
Legacy Keywords
renal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitorrenal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitor
Legacy Keywords
renal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitorrenal cell, carcinoma, RCC, cancer, kidney, pazopanib, Votrient, tyrosine kinase inhibitor
Sections
Pharmacology
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media